Known targets — ChEMBL curated mechanism
CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D
The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 13/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2009904 | 0.87 | PTGS1 (0.58) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| SCHEMBL2009906 | 0.87 | PTGS1 (0.58) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| Acetic Acid SCHEMBL31635217 | 0.85 | PTGS1 (0.54) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL27681737 | 0.85 | PTGS1 (0.56) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| Ether SCHEMBL21810687 | 0.83 | PTGS1 (0.54) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| Alcohol SCHEMBL27660651 | 0.83 | VNN1 (0.65) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| SCHEMBL8417457 | 0.82 | VNN1 (0.68) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| SCHEMBL8417455 | 0.82 | VNN1 (0.68) | VNN1PTGS1KCNH2CYP3A4CYP2D6 | |
| Niacin SCHEMBL810843 | 0.80 | VNN1 (0.53) | VNN1CYP3A4 | |
| Panthenol SCHEMBL27830055 | 0.80 | PTGS1 (0.61) | VNN1PTGS1KCNH2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024071313-A1 | COSMETIC COMPOSITION AND COSMETIC | 株式会社日本触媒 | 2024-04-04 | — | — | WO | disclosed |
| US-20240009092-A1 | COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240009092-A1 | COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID | PLIN5, PHOSPHO1, PLIN3 | VNN1 827/4885PTGS1 2369/4885KCNH2 1034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.